Innominate Vein Stenosis in Breast Cancer Patients after Totally Implantable Venous Access Port Placement

2015 ◽  
Vol 16 (4) ◽  
pp. 315-320 ◽  
Author(s):  
Myung Gyu Song ◽  
Tae-Seok Seo ◽  
Eun Young Kang ◽  
Hwan Seok Yong ◽  
Jae Hong Seo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Venous Access ◽  
Innominate Vein ◽  
Breast Cancer Patients ◽  
Port Placement ◽  
Access Port ◽  
Venous Access Port ◽  
Vein Stenosis

Effect of catheter diameter on left innominate vein in breast cancer patients after totally implantable venous access port placement

2018 ◽  
Vol 19 (6) ◽  
pp. 615-619 ◽  
Author(s):  
Myung Gyu Song ◽  
Tae-Seok Seo ◽  
Yun Hwan Kim ◽  
Sung Bum Cho ◽  
Hwan Hoon Chung ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Venous Access ◽  
Innominate Vein ◽  
Breast Cancer Patients ◽  
Port Placement ◽  
Access Port ◽  
Venous Access Port ◽  
Left Innominate Vein ◽  
Vein Stenosis

The effect of catheter diameter on left innominate vein stenosis in breast cancer patients after totally implantable venous access port placement. Purpose: To evaluate the effect of catheter diameter on left innominate vein stenosis in breast cancer patients after placement of totally implantable venous access ports. Materials and methods: Totally implantable venous access ports were placed via the left internal jugular vein in 241 women with right breast cancer from January 2010 to December 2014 (mean age, 51.5 years; range, 19–83 years). There were 67 totally implantable venous access ports with a 6.5F catheter and 142 totally implantable venous access ports with an 8F catheter. Medical records were retrospectively reviewed. The presence of significant left innominate vein stenosis and tip location of the catheter was evaluated on chest computed tomography images. Statistical analysis was performed. Results: Left innominate vein stenosis developed in 1 (1.5%) and 13 (9.2%) patients after implantation with 6.5 and 8F catheters, respectively. Difference in the cumulative incidence of left innominate vein stenosis was statistically significant between the two groups (log rank test p-value: 0.002). In Cox regression analysis, the hazard ratio for left innominate vein stenosis was 20.766 ( p = 0.005) for an 8F catheter. Conclusion: The incidence of left innominate vein stenosis was higher after implantation of totally implantable venous access ports with 8F catheter rather than with 6.5F catheter. Considering that using 8F catheter versus 6.5F catheter has no advantage in terms of performance of the device, the results of our study suggest that ports with catheters >7F should be avoided.

scholarly journals Ultrasound-guided totally implantable venous access ports via the right innominate vein: a new approach for patients with breast cancer

2019 ◽  
Vol 17 (1) ◽  
Author(s):  
Liang Xu ◽  
Wenming Qin ◽  
Weiwei Zheng ◽  
Xingwei Sun
Keyword(s):  
Breast Cancer ◽  
Postoperative Complications ◽  
Success Rate ◽  
Cancer Patients ◽  
Venous Access ◽  
Innominate Vein ◽  
Breast Cancer Patients ◽  
Ultrasound Guided ◽  
Access Port ◽  
The Right

Abstract Background To evaluate the feasibility and safety of ultrasound-guided totally implantable venous access port (TIVAP) implantation via the right innominate vein in patients with breast cancer. Methods Sixty-seven breast cancer patients underwent ultrasound-guided implantation of TIVAPs via the right innominate vein for administration of chemotherapy. Clinical data including technical success, success rate for the first attempt, periprocedural, and postoperative complications were recorded and retrospectively studied. Results All patients underwent successful surgery. The success rate of the first attempt was 95.52% (64/67). The operation time was 28 to 45 min, with an average of 36 ± 6 min. Periprocedural complications included artery punctures in 1 (1.50%, 1/67) patient. Prior to this study, the mean TIVAP time was 257 ± 3 days (range 41 to 705 days). The rate of postoperative complications was 4.48% (3/67), including catheter-related infections in 1 case and fibrin sheath formation in 2 cases. Up to the present study, three people had unplanned port withdrawal due to complications, and the TIVAPs for 25 patients were still in normal use. Conclusions The success rate of ultrasound-guided TIVAPs via the right innominate vein is high with low complications, thus safe and feasible. This technique can provide a new option for chemotherapy of breast cancer patients.

Totally Implantable Venous Access Port Systems: Implant Depth-based Complications in Breast Cancer Therapy - A Comparative Study

2021 ◽  
Vol 27 ◽  
Author(s):  
Kuo Chen ◽  
Narasimha M. Beeraka ◽  
Yuanting Gu ◽  
Jingruo Li ◽  
Mikhail Sinelnikov ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Therapy ◽  
Venous Access ◽  
Breast Cancer Patients ◽  
Breast Cancer Therapy ◽  
Access Port ◽  
Group A ◽  
Venous Access Port ◽  
Group B ◽  
Group D

Background: Totally implantable venous access port system (TIVAPS) is widely used in breast cancer therapy; TIVAPS has several associated complications depending on the depth of implantation in breast cancer (BC) patients during continuous infusional chemotherapy regimens. The purpose of this study is to find out the optimal depth of TIVAPS implantation to reduce the incidence of complications during infusional chemotherapy. Methods: This study reviewed the depth TIVAPS implantation in the internal jugular vein in 1282 breast cancer patients over a ten-year period (2009-2019), and associated complications. We segregated the patients as 5 groups: ‘Group A (depth < 4 mm), Group B (depth of 4-8 mm), Group C (depth of 8-12 mm), and Group D (depth of 12-16 mm), and Group E (depth of > 16 mm)’. Consequently, the ‘internal complications’ such as infection, venous thrombotic syndrome, catheter folding & migration, extravasation, whereas the ‘external complications’ viz., inflammation, local hematoma, local cutaneous reactions, and port exteriorization were significantly analyzed during TIVAPS implantation at different depths in BC patients. Results: Overall incidence of ‘internal complications’ such as infections, venous thrombotic syndrome, catheter folding & migration, and extravasation was comparatively lesser in Group C (8-12 mm) than Group A, Group B, Group D, and Group E, respectively. Mainly, the external complications such as inflammation Group C (8-12 mm) (p<0.01) were lesser (6.8%, 3/44 cases) than Group A, Group B, Group D, Group E. On a similar note, the local hematoma, and local cutaneous reaction, and port exteriorization were observed as ‘5% (1/20 cases), 4.2% (2/47 cases), and (3.2%, 1/31 cases)’ in Group C patients (p<0.01), which were comparatively lesser than the other groups. Conclusion: Subcutaneous implantation of TIVAPS at a depth of 8-12 mm could be preferred due to the lowest incidence of internal and external complications compared to the incidence of these complications in other groups; this depth could be referred to as the safe and convenient implantation depth for the effective delivery of chemotherapy regimen in BC patients without difficulty in transcutaneous access to the port.

scholarly journals Characteristics of Symptomatic Axillary Vein Thrombosis After Placement of Totally Implanted Venous Access Port in Cancer Patients

2020 ◽  
Vol 17 (3) ◽  
Author(s):  
Myung Gyu Song ◽  
Tae-Seok Seo ◽  
Woo Jin Yang
Keyword(s):  
Lung Cancer ◽  
Pancreatic Cancer ◽  
Venous Thrombosis ◽  
Cancer Patients ◽  
Venous Access ◽  
Axillary Vein ◽  
Access Port ◽  
Vein Thrombosis ◽  
Axillary Vein Thrombosis ◽  
Venous Access Port

Background: The incidence of venous thrombosis based on access route after implantation of the totally implanted venous access port (TIVAP) is controversial. Symptomatic TIVAP-related venous thrombosis remains relatively rare. However, characteristics of symptomatic axillary vein thrombosis after TIVAP implantation via access of the axillary vein has not been reported. Objectives: In this historical cohort study, the incidence and characteristics of venous thrombosis associated with TIVAP via the axillary vein in cancer patients were evaluated. Patients and Methods: A total of 4,773 TIVAPs were placed via the axillary vein in patients with various types of cancer between May 2012 and July 2018. Eighteen patients experienced symptomatic venous thrombosis associated with TIVAPs. Radiologic findings for venous thrombosis were evaluated using computed tomography (CT) including scans of the axillary vein. Medical records were retrospectively reviewed. Results: The prevalence of symptomatic thrombosis was 0.38% (18/4,773). The patients with symptomatic venous thrombosis included 14 males and four females. Among the 18 patients, the most common types of cancer were lung cancer (n = 7) and pancreatic cancer (n = 4), with the incidence rates of 0.79% (lung cancer, 7/882) and 1.58% (pancreatic cancer, 4/253), respectively. The median time between placement of the TIVAP and diagnosis of thrombosis was 35.5 days (range: 6 - 292 days). All symptomatic patients had thrombosis in the axillary vein on CT images. Symptoms were improved in all patients with treatment including removal of TIVAP at the time of diagnosis and following anticoagulation therapy. From the multiple binary logistic regression, pancreatic cancer and lung cancer were statistically significant risk factors of symptomatic axillary vein thrombosis. Conclusion: After insertion of TIVAPs through the axillary vein, symptomatic axillary vein thrombosis rarely developed. Pancreatic cancer and lung cancer were associated with the risk of symptomatic axillary vein thrombosis.

scholarly journals Risk factor for occlusion of central venous access port system in colon cancer patients

2013 ◽  
Vol 8 (1) ◽  
pp. 135-141
Author(s):  
Hisakazu Nishimori ◽  
Noriko Kouge ◽  
Hitomi Nishimoto ◽  
Yuko Tsuyumu ◽  
Yukie Matsushima ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Risk Factor ◽  
Cancer Patients ◽  
Central Venous Access ◽  
Venous Access ◽  
Central Venous ◽  
Access Port ◽  
Port System ◽  
Venous Access Port
Sign in / Sign up

Export Citation Format

Share Document